News

Patients with type 2 diabetes are less likely to develop prostate cancer. On the other hand, their prognosis is worse when prostate cancer is diagnosed. Afterloading therapy achieves the best results in advanced-stage tumors.

International metastudy: brachytherapy at least equivalent or superior to radical surgery.

Great advantage for patients who are dependent on anticoagulant medication.

As one of the highest-case volume centers in Europe, the WPZ specializes in prostate treatment.

COPCa study: which treatment do patients with low-risk prostate cancer choose?

Significant decrease in mortality and metastasis in PSA-tested men.

Recent results from the two-year SPIRIT trial demonstrate clear benefits for brachytherapy.

Prostate cancer patients benefit from intensive follow-up at the West German Prostate Center.

Dr. Derakhshani on the possibilities and limitations of focal therapy.

Experimental method with risk of overtherapy.

HIFU in prostate cancer remains an experimental procedure

Dr. Stephan Neubauer is recommended twice as a TOP physician by FOCUS-GESUNDHEIT.